ePrivacy and GPDR Cookie Consent by TermsFeed Generator

We use cookies to provide website functionality, to analyze site usage, to enable social media features and assist in our marketing efforts. Only Necessary Cookies will be stored by default, and by clicking "Accept and Close", you agree to the storage of all cookies on your device. For more information about the use of cookies please see our "Cookie Policy" web page.


Speakers.

Victoria Speed

Specialist anticoagulation pharmacist at King’s College Hospital, London.

Successfully defended PhD on the use of rivaroxaban for the treatment of venous thromboembolism under the supervision of Professor Roopen Arya and Dr. Jignesh Patel at the Institute of Pharmaceutical Science, King’s College London in January 2022.

Sub-investigator for the FIRST Registry, a UK wide, multicentre, investigator led, prospective registry that investigated the long-term complications of rivaroxaban for the treatment of VTE.

Population pharmacokinetic modelling of rivaroxaban with a special interest in extremes of bodyweight.

NTW22 Speaker | Victoria Speed